Literature DB >> 1373895

Mutation in the primer binding site of the type 1 human immunodeficiency virus genome affects virus production and infectivity.

T Nagashunmugam1, A Velpandi, C S Goldsmith, S R Zaki, V S Kalyanaraman, A Srinivasan.   

Abstract

In an effort to understand the contribution of the primer-binding site (PBS) region to human immunodeficiency virus (HIV) replication, we have constructed a mutant HIV proviral DNA with an alteration in the 5' end of the PBS. The PBS mutant proviral DNA was characterized by transfection of the viral DNA into CD4+ and non-CD4+ target cells. The results indicate that mutation in the PBS reduced the level of viral particles released into the medium of transfected cells in comparison to wild-type proviral DNA. The viral particles were noninfectious upon transmission to established CD4+ cell lines and phytohemagglutinin-stimulated peripheral blood lymphocytes. Electron microscopic analysis of the transfected cells revealed no abnormalities in the structure of the virion directed by the mutant proviral DNA. Also, the protein and RNA contents of the mutant virions were similar to the wild type. The quantitation of intracellular viral structural protein in the transfected cells, however, indicated that the PBS mutation may have an effect on the assembly of viral particles in addition to completely abolishing reverse transcription of viral RNA into DNA. These results provide evidence that the PBS region of the viral genome has multiple functions in HIV-1 replication.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1373895      PMCID: PMC525643          DOI: 10.1073/pnas.89.9.4114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Studies on human immunodeficiency virus-induced cytopathic effects: use of human rhabdomyosarcoma (RD) cells.

Authors:  A Srinivasan; C S Goldsmith; D York; R Anand; P Luciw; G Schochetman; E Palmer; C Bohan
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

2.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.

Authors:  A Adachi; H E Gendelman; S Koenig; T Folks; R Willey; A Rabson; M A Martin
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

3.  Chromosomal position or virus mutation permits retrovirus expression in embryonal carcinoma cells.

Authors:  E Barklis; R C Mulligan; R Jaenisch
Journal:  Cell       Date:  1986-11-07       Impact factor: 41.582

4.  A potential primer for reverse transcription of mdg3, a Drosophila copia-like element, is a leucine tRNA lacking its 3' terminal 5 bases.

Authors:  K Saigo
Journal:  Nucleic Acids Res       Date:  1986-05-27       Impact factor: 16.971

5.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

6.  Secondary structural features in the 70S RNAs of Moloney murine leukemia and Rous sarcoma viruses as observed by electron microscopy.

Authors:  K G Murti; M Bondurant; A Tereba
Journal:  J Virol       Date:  1981-01       Impact factor: 5.103

7.  Structure-function relationship of Rous sarcoma virus leader RNA.

Authors:  J L Darlix; M Zuker; P F Spahr
Journal:  Nucleic Acids Res       Date:  1982-09-11       Impact factor: 16.971

8.  A new pathway in the generation of defective retrovirus DNA.

Authors:  J C Olsen; R Swanstrom
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

9.  Molecular characterization of human immunodeficiency virus from Zaire: nucleotide sequence analysis identifies conserved and variable domains in the envelope gene.

Authors:  A Srinivasan; R Anand; D York; P Ranganathan; P Feorino; G Schochetman; J Curran; V S Kalyanaraman; P A Luciw; R Sanchez-Pescador
Journal:  Gene       Date:  1987       Impact factor: 3.688

10.  Active human immunodeficiency virus protease is required for viral infectivity.

Authors:  N E Kohl; E A Emini; W A Schleif; L J Davis; J C Heimbach; R A Dixon; E M Scolnick; I S Sigal
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

View more
  13 in total

1.  Selection of functional tRNA primers and primer binding site sequences from a retroviral combinatorial library: identification of new functional tRNA primers in murine leukemia virus replication.

Authors:  A H Lund; M Duch; F S Pedersen
Journal:  Nucleic Acids Res       Date:  2000-02-01       Impact factor: 16.971

2.  HIV-1 Gag shares a signature motif with annexin (Anx7), which is required for virus replication.

Authors:  M Srivastava; M Cartas; T A Rizvi; S P Singh; D Serio; V S Kalyanaraman; H B Pollard; A Srinivasan
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

3.  Development of a novel anti-HIV-1 agent from within: effect of chimeric Vpr-containing protease cleavage site residues on virus replication.

Authors:  D Serio; T A Rizvi; M Cartas; V S Kalyanaraman; I T Weber; H Koprowski; A Srinivasan
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

4.  Effects of alterations of primer-binding site sequences on human immunodeficiency virus type 1 replication.

Authors:  X Li; J Mak; E J Arts; Z Gu; L Kleiman; M A Wainberg; M A Parniak
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

5.  Extended minus-strand DNA as template for R-U5-mediated second-strand transfer in recombinational rescue of primer binding site-modified retroviral vectors.

Authors:  J G Mikkelsen; A H Lund; K Dybkaer; M Duch; F S Pedersen
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

6.  Complementation of a primer binding site-impaired murine leukemia virus-derived retroviral vector by a genetically engineered tRNA-like primer.

Authors:  A H Lund; M Duch; J Lovmand; P Jørgensen; F S Pedersen
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

7.  Efficient encapsidation of human immunodeficiency virus type 1 vectors and further characterization of cis elements required for encapsidation.

Authors:  M S McBride; M D Schwartz; A T Panganiban
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

8.  Human immunodeficiency virus type 1 can use different tRNAs as primers for reverse transcription but selectively maintains a primer binding site complementary to tRNA(3Lys).

Authors:  J K Wakefield; A G Wolf; C D Morrow
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

9.  Minimal sequence requirements of a functional human immunodeficiency virus type 1 primer binding site.

Authors:  J K Wakefield; H Rhim; C D Morrow
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

10.  Secondary structure of the HIV-2 leader RNA comprising the tRNA-primer binding site.

Authors:  B Berkhout; I Schoneveld
Journal:  Nucleic Acids Res       Date:  1993-03-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.